Joseph Wolk
Director of Finance/CFO bei JOHNSON & JOHNSON
Vermögen: 11 Mio $ am 31.03.2024
Profil
Joseph J. Wolk hat die Position des Chief Financial Officer & Executive Vice President bei Johnson & Johnson inne. Herr Wolk ist außerdem Mitglied des Cnbc Global Cfo Council. Herr Wolk erwarb einen Bachelor-Abschluss an der St. Joseph's University und einen Master-Abschluss an der Temple University Beasley School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
JOHNSON & JOHNSON
0,00% | 15.02.2024 | 70 938 ( 0,00% ) | 11 Mio $ | 31.03.2024 |
KENVUE, INC.
0,00% | 23.08.2023 | 538 ( 0,00% ) | 11 545 $ | 31.03.2024 |
Aktive Positionen von Joseph Wolk
| Unternehmen | Position | Beginn |
|---|---|---|
| JOHNSON & JOHNSON | Director of Finance/CFO | 01.07.2018 |
| KENVUE INC. | Director/Board Member | 08.05.2023 |
Cnbc Global Cfo Council
 Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Corporate Officer/Principal | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Wall Street Journal Cfo Network
 Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Corporate Officer/Principal | - |
| St. Joseph's University | Director/Board Member | - |
Ehemalige bekannte Positionen von Joseph Wolk
| Unternehmen | Position | Ende |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Director of Finance/CFO | 01.01.2016 |
Ausbildung von Joseph Wolk
| St. Joseph's University | Undergraduate Degree |
| Temple University Beasley School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| KENVUE INC. | Consumer Non-Durables |
| Private Unternehmen | 3 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Cnbc Global Cfo Council
Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Commercial Services |
Wall Street Journal Cfo Network
Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Commercial Services |
